Moderate to severe ME/CFS with POTS, better on a five-day course then relapsed
- Condition
- ME/CFS
- At worst
- Severe (mostly bedbound)
- Ill before improving or writing
- Not stated
- Last post
- Jan 2024
In their words
- Condition: ME/CFS
I’m 23(M) and moderate to severe MECFS + POTS
In context ↗ - At worst: Severe
moderate to severe MECFS + POTS
In context ↗ - Now: Relapsed
my ME symptoms significantly improved, along with the covid I caught ... I found the effects stopped within 10-14 days
In context ↗
Read from 4 of their posts and comments; links to the 4 this page draws on
Summary
A 23-year-old Australian man with moderate to severe ME/CFS and POTS reviewed a portable mobility scooter for outings in 2019. By early 2024 he was trying to manage insomnia and still had ME/CFS. When he caught COVID in January 2024 and took a five-day course of medication, his ME symptoms improved significantly, but the effect stopped within 10 to 14 days; another course would cost $1,115 AUD.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- Moving Life Atto folding mobility scooter · Helped
POTS and CFS become less of an obstacle where it can be used.
In context ↗ - Paxlovid · Helped a lot
I’ve had a similar experience where my ME symptoms significantly improved, along with the covid I caught.
In context ↗ - Garmin Vivoactive 4 with Bearable symptom tracking app · No change
Garmin is hopeless for insomnia, and doesn’t track naps.
In context ↗
Approaches: Antivirals
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened | Where they were | After |
|---|---|---|---|
| 2019 | moderate to severe ME/CFS and POTS, used a portable mobility scooter for outingsI’m 23(M) and moderate to severe MECFS + POTSIn context ↗ | Moderate | |
| early January 2024 | caught COVID and took a five-day course of Paxlovid; ME symptoms improved significantlyI’ve had a similar experience where my ME symptoms significantly improved, along with the covid I caught.In context ↗ | Not stated | Paxlovid / nirmatrelvir |
| January 2024 | benefit stopped after 10-14 daysI found the effects stopped within 10-14 days.In context ↗ | Not stated | |
| 2024-01-27 | relapse/crash while still managing ME/CFS and insomniathese hit my angry, sad and disappointed emotions upon having a relapse/crash.In context ↗ | Not stated |
Symptoms mentioned
Their words about their symptoms
- POTS & dysautonomia
moderate to severe MECFS + POTS
In context ↗ - Sleep problems
Trying to manage insomnia and my ME/CFS symptoms.
In context ↗
Ask Miruvor AI
Similar stories
-
Bedridden with long COVID for three years, now nearly back to normal with time and pacing
Caught COVID in December 2019, before lockdown, and was mostly bedridden for three years as symptoms worsened. From year three she improved slowly, crediting time, rest, pacing, a gradual walking programme, daily antihistamines and gabapentin. A 2023…
-
Bedridden or housebound with long COVID, now much better with pacing and LDN
Ill from February 2020, they were often bedridden or housebound with severe pain, headaches, diarrhoea and suicidal depression. They credit diet changes, rest and pacing, LDN and Celebrex for slow gains, and Auvelity for their depression, though flare-ups…
-
Long COVID 80% recovered with LDN, then a workout crash left them housebound
Zephyr 10189 fell ill with long COVID in early 2022. By 19 months they were about 80% recovered, crediting LDN, antihistamines and gut treatments. A 20-minute leg workout, reported in June 2024, caused a crash with heavy, cramping limbs; by August 2024 they…
-
Not enough detail to draw a path
ME/CFS cost them their job; now walks a few blocks, brain fog cleared during a trial
Creek 79369 had ME from college in 2014, likely EBV-triggered, and paced to manage it until a March 2020 COVID infection set them back. They deteriorated through an office job and quit in January 2025. Over the past year their energy envelope widened; by…